Precision Biosciences Inc (DTIL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -109,006 | -92,877 | -46,037 | -21,102 | N/A |
| Depreciation Amortization | 9,813 | 5,317 | 2,354 | 1,553 | N/A |
| Accounts receivable | -9,035 | -441 | -523 | N/A | N/A |
| Accounts payable and accrued liabilities | -1,455 | 667 | -673 | 864 | N/A |
| Other Working Capital | -2,014 | -2,357 | -10,507 | -5,095 | N/A |
| Other Operating Activity | 24,311 | 18,676 | 3,663 | -389 | 0 |
| Operating Cash Flow | $-87,386 | $-71,015 | $-51,723 | $-24,169 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -5,031 | -24,666 | -14,263 | -5,515 | N/A |
| Net Acquisitions | N/A | N/A | -1,400 | N/A | N/A |
| Investing Cash Flow | $-5,031 | $-24,666 | $-15,663 | $-5,515 | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 39,550 | N/A | N/A | N/A |
| Common Stock Issued | 1,329 | 136,446 | 171 | 15 | N/A |
| Common Stock Repurchased | N/A | N/A | N/A | -952 | N/A |
| Other Financing Activity | 0 | -2,622 | 107,606 | 0 | 0 |
| Financing Cash Flow | $1,329 | $173,374 | $107,777 | $-937 | $N/A |
| Beginning Cash Position | 180,886 | 103,193 | 62,802 | 93,423 | N/A |
| End Cash Position | 89,798 | 180,886 | 103,193 | 62,802 | N/A |
| Net Cash Flow | $-91,088 | $77,693 | $40,391 | $-30,621 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -87,386 | -71,015 | -51,723 | -24,169 | N/A |
| Capital Expenditure | -5,031 | -24,666 | -14,278 | -5,565 | N/A |
| Free Cash Flow | -92,417 | -95,681 | -66,001 | -29,734 | 0 |